KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,836,300 | -16.2% | 70,000 | +7.5% | 0.01% | -10.0% |
| Q2 2023 | $14,116,935 | +30.8% | 65,100 | +9.6% | 0.01% | +42.9% |
| Q1 2023 | $10,789,416 | -15.0% | 59,400 | -8.0% | 0.01% | -22.2% |
| Q4 2022 | $12,693,900 | -10.8% | 64,600 | +2.1% | 0.01% | -10.0% |
| Q3 2022 | $14,238,000 | +114.0% | 63,300 | +20.3% | 0.01% | +100.0% |
| Q2 2022 | $6,654,000 | +6.9% | 52,600 | +7.1% | 0.01% | +25.0% |
| Q1 2022 | $6,225,000 | +4.7% | 49,100 | +8.1% | 0.00% | 0.0% |
| Q4 2021 | $5,947,000 | +6.8% | 45,400 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $5,566,000 | +17.1% | 45,500 | +9.1% | 0.00% | +33.3% |
| Q2 2021 | $4,753,000 | +43.2% | 41,700 | +51.1% | 0.00% | +50.0% |
| Q1 2021 | $3,318,000 | +20.5% | 27,600 | +1.8% | 0.00% | 0.0% |
| Q4 2020 | $2,753,000 | +33.4% | 27,100 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $2,064,000 | -29.3% | 26,700 | +1.9% | 0.00% | 0.0% |
| Q2 2020 | $2,920,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |